Regulating the genome surveillance system: miRNAs and the p53 super family

被引:0
作者
Sarah G. Bailey
Tilman Sanchez-Elsner
Anastasis Stephanou
Mark S. Cragg
Paul A. Townsend
机构
[1] University of Southampton,Human Genetics Division, School of Medicine
[2] University of Southampton,Division of Infection, Inflammation and Immunity, School of Medicine
[3] University College London,Medical Molecular Biology Unit, Institute of Child Health
[4] University of Southampton,Cancer Sciences Division, School of Medicine
来源
Apoptosis | 2010年 / 15卷
关键词
p73; miRNA; p53; Leukaemia; Lymphoma;
D O I
暂无
中图分类号
学科分类号
摘要
The p53 gene super family consists of three members; TP53, TP63 and TP73, encoding proteins p53, p63 and p73. Whilst p63 appears to have an essential role in embryonic development with a less clear role in carcinogenesis, irregularities in p53 and p73 signalling are implicated in tumour formation. As such, p53 is a tumour suppressor which is mutated in over 50% cancers and p73 was recently formally classified as a tumour suppressor based on data showing p73 deficient mice generate spontaneous tumours similar to those observed in p53 null mice. Dysregulation of both p53 and p73 has been correlated with cancer progression in many cell types and although mutation of these genes is often observed, some form of p53/p73 deregulation likely occurs in all tumour cells. The discovery that complementary micro RNAs (miRNAs) are able to target both of these genes provides a potential new means of perturbing p53/p73 signalling networks in cancer cells. Here we summarise the current literature regarding the involvement of miRNAs in the modulation of p53 family proteins and cancer development and detail the use of in silico methods to reveal key miRNA targets.
引用
收藏
页码:541 / 552
页数:11
相关论文
共 500 条
  • [1] Lukas J(2004)Mammalian cell cycle checkpoints: signalling pathways and their organization in space and time DNA Repair (Amst) 3 997-1007
  • [2] Lukas C(2001)Pathways governing G1/S transition and their response to DNA damage FEBS Lett 490 117-122
  • [3] Bartek J(2002)Dissecting p53 tumour suppressor functions in vivo Cancer Cell 1 289-298
  • [4] Bartek J(2002)Activation of p53 by protein inhibitor of activated Stat1 (PIAS1) J Biol Chem 277 8255-8259
  • [5] Lukas J(2001)A putative protein inhibitor of activated STAT (PIASy) interacts with p53 and inhibits p53-mediated transactivation but not apoptosis Apoptosis 6 221-234
  • [6] Schmitt CA(2007)How important are post-translational modifications in p53 for selectivity in target-gene transcription and tumour suppression? Cell Death Differ 14 1561-1575
  • [7] Fridman JS(2008)Protein methylation: a new mechanism of p53 tumour suppressor regulation Histol Histopathol 23 1143-1149
  • [8] Yang M(1997)DNA damage induces phosphorylation of the amino terminus of p53 Genes Dev 11 3471-3481
  • [9] Baranov E(2007)p53 is regulated by the lysine demethylase LSD1 Nature 449 105-108
  • [10] Hoffman RM(2006)DeltaTAp73 upregulation correlates with poor prognosis in human tumors: putative in vivo network involving p73 isoforms, p53, and E2F–1 J Clin Oncol 24 805-815